• Skip to main content
  • Skip to header right navigation
  • Skip to site footer

Log in
www.sages.org

SAGES

Reimagining surgical care for a healthier world

  • Home
    • SAGES Home
    • SAGES Foundation Home
  • About
    • Awards
    • Who Is SAGES?
    • Leadership
    • Our Mission
    • Advocacy
    • Committees
      • SAGES Board of Governors
      • Officers and Representatives of the Society
      • Committee Chairs and Co-Chairs
      • Committee Rosters
      • SAGES Past Presidents
    • Why Should You Support SAGES?
    • SAGES Swag
  • Meetings
    • SAGES NBT Innovation Weekend
    • SAGES Annual Meeting
      • 2026 Annual Meeting
      • 2027 Scientific Session Call for Abstracts
      • 2027 Emerging Technology Call for Abstracts
    • CME Claim Form
    • SAGES Past, Present, Future, and Related Meeting Information
    • SAGES Related Meetings & Events Calendar
  • Join SAGES!
    • Membership Application
    • Membership Benefits
    • Membership Types
      • Requirements and Applications for Active Membership in SAGES
      • Requirements and Applications for Affiliate Membership in SAGES
      • Requirements and Applications for Associate Active Membership in SAGES
      • Requirements and Applications for Candidate Membership in SAGES
      • Requirements and Applications for International Membership in SAGES
      • Requirements for Medical Student Membership
    • Member Spotlight
    • Give the Gift of SAGES Membership
  • Patients
    • Join the SAGES Patient Partner Network (PPN)
    • Patient Information Brochures
    • Healthy Sooner – Patient Information for Minimally Invasive Surgery
    • Choosing Wisely – An Initiative of the ABIM Foundation
    • All in the Recovery: Colorectal Cancer Alliance
    • Find A SAGES Surgeon
  • Publications
    • Clinical / Practice / Training Guidelines, Statements, and Standards of Practice
    • Sustainability in Surgical Practice
    • SAGES Stories Podcast
    • SAGES Lead Up Podcast
    • Patient Information Brochures
    • Patient Information From SAGES
    • TAVAC – Technology and Value Assessments
    • Surgical Endoscopy and Other Journal Information
    • Innovative Surgical Trends
    • SAGES Manuals
    • MesSAGES – The SAGES Newsletter
    • COVID-19 Archive
    • Troubleshooting Guides
  • Education
    • Wellness Resources – You Are Not Alone
    • Avoid Opiates After Surgery
    • SAGES Subscription Catalog
    • SAGES TV: Home of SAGES Surgical Videos
    • The SAGES Safe Cholecystectomy Program
    • Masters Program
    • Resident and Fellow Opportunities
      • MIS Fellows Course
      • SAGES Robotics Residents and Fellows Courses
      • SAGES Free Resident Webinar Series
      • Advanced Laparoscopy and Fluorescence-Guided Surgery Course for Fellows
      • Fellows’ Career Development Course
    • SAGES S.M.A.R.T. Enhanced Recovery Program
    • SAGES @ Cine-Med Products
      • SAGES Top 21 Minimally Invasive Procedures Every Practicing Surgeon Should Know
      • SAGES Pearls Step-by-Step
      • SAGES Flexible Endoscopy 101
    • SAGES OR SAFETY Video Activity
    • Foregut Video Atlas
  • Opportunities
    • Join the SAGES Patient Partner Network (PPN)
    • Fellowship Recognition Opportunities
    • SAGES Advanced Flexible Endoscopy Area of Concentrated Training (ACT) SEAL
    • Multi-Society Foregut Fellowship Certification
    • Research Opportunities
    • FLS
    • FES
    • FUSE
    • Jobs Board
    • SAGES Go Global: Global Affairs
  • Learning Hub
You are here: Home / Abstracts / Laparoscopic Segmental Gastrectomy for a Mid-Stomach Gastrointestinal Stromal Tumor

Laparoscopic Segmental Gastrectomy for a Mid-Stomach Gastrointestinal Stromal Tumor

Gabriela Chullo, Resident, Roser Termes, Resident, Ainitze Ibarzabal, Specialist, Dulce Momblan, Specialist, Victor Turrado, Specialist, Antonio Lacy, Specialist. Hospital Clinic de Barcelona

INTRODUCTION: Gastrointestinal stromal tumors (GIST) are the most common mesenchymal tumors of the gastrointestinal tract. GIST are considered a low malignancy tumors. The risk of recurrence is based on tumor size and mitotic index.  Radical surgical resection is the standard treatment in localized primary GIST. Surgical margins of 10 mm free from tumor involvement are sufficient since surgical aggressiveness with wide margins of resection is not related to an increase in survival or decrease in the risk of relapse and, nevertheless, the involvement of the resection margins or simple enucleation of the tumor is subject to a high rate of relapse. GISTs rarely metastasize via the lymphatic system, so regional lymphadenectomy would not be necessary.

Laparoscopic resection has been increasingly adopted, being widely accepted as a reasonable approach to treat GIST with reported similar operative time and survival rates, but shorter hospital stay compared with open resection.

In this video we show a mid gastric resection and anastomosis of a gastric GIST.

METHODS AND PROCEDURES: We present the case of a 67-year-old female patient diagnosed in July 2017 with gastric GIST following abdominal discomfort and dyspepsia. The gastroscopy showed a mid-stomach lesion without ulceration or mucosal involvement. Computed tomography (CT) showed a submucosal gastric tumor, depending on the anterior wall of the gastric body. The tumor had a maximum diameter of 57 mm and suggested a GIST. No signs of dissemination were observed.

Endoscopic ultrasonography showed a well-defined, hypoechoic and heterogeneous lesion measuring 53 x 51mm in diameter and the ultrasound-guided needle biopsy confirmed GIST, positive immunohistochemical staining of CD117.

The patient received neoadjuvant treatment with Imatinib during 10 months, showing mild radiological response.

Laparoscopic resection in the mid-stomach was  successfully performed. A side to side  anastomosis was performed with manual suture .

RESULTS: The operation time was performed in 180 minutes, no intraoperative complications occurred, and clear fluid intake was started on the first post-operative day. The patient had an uneventful postoperative course, and a hospital stay of three days.

The histological result showed a 70x 50 x 40 mm tumor with low mitotic index and negative surgical margins.

The patient actually is asymptomatic and re-started the treatment with Imatinib.

CONCLUSIONS: In patients with resectable GIST, surgery continues to be the best treatment. Laparoscopic surgery is a safe and effective procedure, with excellent oncological results. Nevertheless, it is necessary to have experience in laparoscopic surgery to avoid tumor ruptures and minimize complications.


Presented at the SAGES 2017 Annual Meeting in Houston, TX.

Abstract ID: 95234

Program Number: V251

Presentation Session: Video Loop Day 2

Presentation Type: VideoLoop

Related



Hours & Info

15821 Ventura Blvd Ste 400
Encino, CA 91436

1-310-437-0544

[email protected]

Monday – Friday
8am to 5pm Pacific Time

Find Us Around the Web!

  • Bluesky
  • X
  • Instagram
  • Facebook
  • YouTube

Copyright © 2026 · SAGES · All Rights Reserved

Important Links

Healthy Sooner: Patient Information

SAGES Guidelines, Statements, & Standards of Practice

SAGES Manuals

Refine Search